Webster Joshua D, Yuzbasiyan-Gurkan Vilma, Kaneene John B, Miller RoseAnn, Resau James H, Kiupel Matti
Comparative Medicine and Integrative Biology Program, College of Veterinary Medicine, Michigan State University, East Lansing, MI 48824, USA.
Neoplasia. 2006 Feb;8(2):104-11. doi: 10.1593/neo.05622.
The c-KIT proto-oncogene has been implicated in the pathogenesis of several neoplastic diseases, including gastrointestinal stromal tumors and mastocytosis in humans, and mast cell tumors (MCTs) in canines. Cutaneous MCTs are common neoplasms in dogs and have a variable biologic behavior. The goal of this study was to define the prognostic significance of c-KIT mutations identified in canine MCTs and the associations between c-KIT mutations, KIT localization, and KIT expression levels. Microdissection and polymerase chain reaction were performed on 60 MCTs to identify c-KIT mutations. Anti-KIT antibodies were used for immunohistochemical evaluation of KIT localization. Forty-two MCTs were included in a tissue microarray, and KIT expression was quantified using immunofluorescence. Canine MCTs with c-KIT mutations were significantly associated with an increased incidence of recurrent disease and death. c-KIT mutations were also significantly associated with aberrant protein localization; however, the level of KIT expression did not correlate with either c-KIT mutations or changes in protein localization. Considering the high prevalence of canine MCTs and the central role of c-KIT in the tumorigenesis of certain tumors, canine MCTs are an excellent model for characterizing the role of c-KIT in neoplastic diseases and is a potential target for novel therapeutic agents in clinical trials.
c-KIT原癌基因已被证实与多种肿瘤性疾病的发病机制有关,包括人类的胃肠道间质瘤和肥大细胞增多症,以及犬类的肥大细胞瘤(MCTs)。皮肤MCTs是犬类常见的肿瘤,具有可变的生物学行为。本研究的目的是确定犬MCTs中鉴定出的c-KIT突变的预后意义,以及c-KIT突变、KIT定位和KIT表达水平之间的关联。对60个MCTs进行显微切割和聚合酶链反应以鉴定c-KIT突变。使用抗KIT抗体对KIT定位进行免疫组织化学评估。42个MCTs被纳入组织微阵列,并使用免疫荧光对KIT表达进行定量。具有c-KIT突变的犬MCTs与疾病复发和死亡发生率增加显著相关。c-KIT突变也与异常的蛋白定位显著相关;然而,KIT表达水平与c-KIT突变或蛋白定位变化均无相关性。考虑到犬MCTs的高发病率以及c-KIT在某些肿瘤发生中的核心作用,犬MCTs是表征c-KIT在肿瘤性疾病中的作用的优秀模型,并且是临床试验中新型治疗药物的潜在靶点。